GRg1 successfully identified and validated six upregulated and twelve downregulated genes, and among the twelve downregulated genes was TRPC6, a transient receptor potential canonical (TRPC) related gene and a molecular entity associated with Ca2+ entry activity and involved in the AD process. Here, TLE1 is linked to Alzheimer disease.